(90.9%) were under treatment with drug, diet control and physical exercise. Regarding sources of fund for treatment, 31.8% patients used their savings while 27.3% took loan, 20% got help from relatives and the remaining 20.9% got donation and sold wealth. Average treatment cost incurred by the patients was estimated to Tk. 5543 
Introduction
Diabetes mellitus is a major concern for the developed as well as developing country like Bangladesh as it poses with enormous disabilities and economic burden to the victims. As an ice-berg disease prevalence of diabetes is more than five times higher at present than it was in the last decade. Currently the number of diabetic patients is estimated to be around 371 million globally in 2012 and this number is predicted to be double by 2025, with the greatest number of cases being expected in developing countries 1, 2 . The treatment cost of diabetes to the patients and society is increasing many folds day by day. Bangladesh is in a far worse position than developed countries where treatment for diabetes is easily available. About 83% of the population of the country live on US $2 a day and it's difficult for people to afford relevant care. But if the 3 million type 2 diabetes had access to free care, the number of years of life would double (5.8 million) and production value would triple 3 . The current prevalence rate of diabetes in Bangladesh is 9.51% and it is supposed to rise to more than 10% in 2025 and almost all are of type 2 DM. In a survey in 2003, documented that a prevalence of diabetes mellitus is 11.2 % among city dwellers of Dhaka aged 20 years and above 4 . At present Bangladesh holds 10th position and will occupy 7th position with 11.1 million in 2030 in terms of number of diabetes patients in the world 5 .
As Armed Forces is the part and parcel of the large population of the country, therefore occurrence of any non communicable disease like diabetes in this community will bear the same impacts like a civil community. 
Results
The Cross sectional study was conducted with an aim of exploring the economic burden of the type 2 diabetes mellitus patients. Results were formulated on the basis of selective variables and written as follows: There was also no statistically significant association found between travel cost and place of residence of the patients. On the other hand there was statistical significant association between treatment cost with sex, marital status and occupation of the patients. As the prevalence of diabetes is increasing day by day, the overall economic burden of diabetic patients is also greatly rising. This study clearly indicates that, enormous economic burden imposed to the diabetic patients definitely reduces their capability to handle such a notorious deadly disease.
Conclusion
This descriptive cross-sectional study was conducted among type 2 DM patients to ascertain economic burden of the disease and also to correlate these with socio-demographic characteristics of the patient. In this study it was reflected that prevalence of the disease was more among productive age group and majority had lower income. The studies also revealed that majority of the patients were retired and had SSC level education. Regarding therapy, most of them were under drug, diet control and physical exercise; among them, majority took oral tablet.
According to the sources for funding of treatment, majority used savings for their treatment. In respect of direct treatment cost, majority of the patients spent more money for attendant cost purpose and for purchasing drugs, while in indirect treatment cost, it is only the amount of loss of income due to illness. Average treatment cost incurred by the patients was found more as indirect treatment cost. There were significant association found between treatment cost with sex, marital status and occupation of the patients.
This study has addressed the economic magnitude of diabetes mellitus in army personnel and which definitely represents the situation in Bangladesh. Finally all those involved in diabetes care need to be aware of what drives cost. Demand for economic research will continue to be increased because of need to assess the growing number of interventions available such as free treatment cost, subsidy, health insurance etc. to minimize the cost incurred by the patients. To reduce economic b u r d e n o f DM, early diagnosis and prompt treatment along with adherence to diabetes therapy is essential. Overall awareness and health education are the prime need to combat this deadly disease as well as to overcome the economic burden of the disease.
